3D-Printed Microenvironments with Programmable Release Capsules
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current 2D cell culture models fail to accurately recapitulate the spatiotemporal aspects of in vivo biological microenvironments, leading to discrepancies in drug efficacy translation from in vitro to in vivo settings, particularly in modeling complex biological phenomena like cancer metastasis.
Innovation Solution
3D-printed model biological microenvironments are created using gel matrices with programmable-release capsules and functional vasculature, enabling precise control of chemical gradients and cell behavior, mimicking the in vivo environment by integrating living cells, biomaterials, and programmable-release capsules that release signaling molecules in a spatiotemporal manner.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If 2D cell culture models are used, then the model simplicity and ease of operation are improved, but the accuracy in recapitulating in vivo biological microenvironments deteriorates
Solution Approach 1:
The patent transitions from 2D cell culture models to 3D-printed microenvironment models, adding spatial dimensionality to accurately recapitulate in vivo biological structures. The 3D printing technology enables creation of three-dimensional extracellular matrices, vascular networks, and tissue architectures that mirror the complexity of living systems, thereby improving model reliability while maintaining operational feasibility through automated printing processes.
Solution Approach 2:
The patent implements local quality by creating spatially heterogeneous microenvironments with region-specific biochemical and physical properties. Different zones within the 3D-printed model can have distinct matrix compositions, stiffness values, growth factor concentrations, and vascular densities, allowing each local region to mimic specific in vivo tissue characteristics. This localized customization enhances the overall accuracy of the model without requiring complete redesign of the entire system.
2Reliability
If 3D-printed model biological microenvironments are created with programmable-release capsules and functional vasculature, then the accuracy in recapitulating in vivo environments is improved, but the device complexity increases
Solution Approach 1:
The patent divides the complex 3D-printed microenvironment into modular functional components: gel matrix scaffold, programmable-release capsules, conduit structures, and cell populations. Each component can be independently designed, printed, and assembled. The programmable-release capsules are segmented into discrete units that can be positioned at specific locations to create controlled chemical gradients, while vasculature is divided into modular conduit segments. This segmentation reduces overall system complexity by enabling independent optimization and assembly of individual components.
Solution Approach 2:
The patent applies preliminary action by pre-embedding programmable-release capsules containing signaling molecules within the gel matrix during the 3D printing process. These capsules are pre-positioned to create specific spatiotemporal chemical gradients before cell introduction. The vascular conduits are pre-formed with controlled porosity and surface properties to guide cell migration patterns. This preliminary configuration of biochemical and structural cues simplifies subsequent experimental procedures and enhances model predictability.
3Manufacturing precision
If precise placement of living cells and programmable-release capsules is achieved through 3D printing, then the manufacturing precision is improved, but the difficulty of manufacture increases
Solution Approach 1:
The patent replaces manual mechanical placement methods with automated 3D printing systems that use computer-controlled extrusion or deposition mechanisms. The 3D printer precisely positions gel matrix material, programmable-release capsules, and cell-laden hydrogels at predetermined coordinates based on digital model files. This mechanical-to-automated substitution achieves sub-millimeter to micrometer-level precision in component placement while reducing manual labor intensity and operational complexity through software-driven control.
Solution Approach 2:
The patent utilizes parameter changes in the 3D printing process to control material properties and placement precision. By adjusting printing parameters such as extrusion rate, layer thickness, nozzle temperature, and deposition speed, the system optimizes the rheological properties of gel matrices and the adhesion characteristics of embedded components. These parameter modifications enable precise control over capsule positioning, cell distribution, and matrix homogeneity, achieving high manufacturing precision while maintaining processability of biomaterials.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These models enhance the translatability of drug effects by recreating the complexity of in vivo environments, allowing for the study of metastasis and drug responses with higher fidelity, improving the prediction of in vivo outcomes and enabling patient-specific therapeutic strategies.
Implementation Method 1
a shell coating that may comprise a plurality of localized surface plasmon resonance (LSPR) particles 3D-printed onto the core, wherein the shell coating is configured to be rupturable by laser irradiation with substantially a resonance wavelength of the LSPR particles
Implementation Method 2
rupture of the shell coating releases the at least one of the target chemical, the molecule, or the one or more cells into the gel matrix such that the target chemical forms the chemical depot within the gel matrix
Implementation Method 3
the target chemical forms a chemical depot within the gel matrix
Data Source
AI summary
A 3D-printed in vitro model biological microenvironment in examples discussed below may have one or more of the following features: (a) a gel matrix 3D-printed scaffold, wherein the gel matrix comprises a chemical composition configured to culture a first type of live cells, (b) a target chemical disposed at one or more locations within the gel matrix, the target chemical forming a chemical depot from which a chemical gradient is created within the gel matrix, (c) a conduit disposed within the gel matrix and defining a lumen comprising a second type of live cells, wherein the conduit is configured to enable at least some of the first type of live cells to migrate through the conduit and facilitate flow of at least: some of the live cells to an outlet of the conduit, or enable introduction of at least one of other cells, Achemical mediators, or drugs into the 3D-printed microenvironment.